Skip to main content

Showing results for Alzheimer's disease

IU researcher member of expert panel on Alzheimer's disease drug

When the Food and Drug Administration approved the use of the drug aducanumab to treat Alzheimer’s disease in early June, leaders in neurodegeneration research quickly created an expert panel to issue guidance to physicians on how to best administer the drug.

IU School of Medicine  |  Sep 08, 2021

IU School of Medicine's Indiana Alzheimer’s Disease Research Center awarded additional $15 million in funding from the National Institute on Aging

Indiana University School of Medicine is pleased to announce its Indiana Alzheimer’s Disease Research Center (IADRC) grant has been renewed for another five years.

IU School of Medicine  |  Sep 07, 2021

IU School of Medicine study shows link between head injury and Alzheimer’s disease

New research from Indiana University School of Medicine shows that the presence of neurodegenerative proteins is associated with common head injury among the general population.

IU School of Medicine  |  Aug 24, 2021

Researchers receive multi-million dollar grant to study early detection of Alzheimer’s disease

A new $11.2 million grant coordinated by the Indiana University School of Medicine from the National Institute on Aging (NIA) will support an international collaboration on multiethnic genomic analysis and advanced brain imaging and other biomarkers for early detection of Alzheimer’s disease.

IU School of Medicine  |  Aug 18, 2021

New study from IU helps researchers understand spreading patterns of Alzheimer's

As new approaches for Alzheimer’s disease diagnosis and treatment emerge, it’s more important than ever to understand the ties between disease pathology, brain connections and genetics.

IU School of Medicine  |  Jul 27, 2021

IU researchers pioneering noninvasive technique for neurological conditions

Indiana University School of Medicine researchers are developing a new, noninvasive brain stimulation technique to treat neurological disorders, including pain, traumatic brain injury (TBI), epilepsy, Parkinson’s disease, Alzheimer’s disease and more.

Christina Griffiths  |  Jul 01, 2021

IU School of Medicine receives $30 million NIA grant for Alzheimer's, related dementia research

National Centralized Repository for Alzheimer’s Disease and Related Dementias (NCRAD) grant has been renewed for another five years with funding expected to total $30 million from the National Institute on Aging (NIA), within the National Institutes of the Health (NIH). NCRAD is led by Tatiana Foroud, PhD, Executive Associate Dean for Research Affairs at IU School of Medicine. Since 2018, NCRAD has been among the five largest grants awarded to IU School of Medicine.

IU School of Medicine  |  Jun 29, 2021

IU School of Medicine researchers develop computer program to predict whether patients could be at high risk for Alzheimer’s and cancer

A group of researchers from Indiana University School of Medicine and Indiana University Bloomington have developed a program called Multi-Omics Graph cOnvolutional NETworks (MOGONET) that integrates omics data – such as DNA, RNA and proteins – to help researchers get a comprehensive understanding of human diseases. MOGONET can identify potential biomarkers for Alzheimer’s disease and cancers from the various omics data to predict which individuals may be at higher risk. 

IU School of Medicine  |  Jun 23, 2021

IU School of Medicine reaches NIH funding milestone, continues record-setting trend

INDIANAPOLIS—For the fifth-straight year, Indiana University School of Medicine set a school record for research funding received from the National Institutes of Health, showcasing its continued leadership in the field of medical research.

IU School of Medicine  |  Jan 27, 2021

IU researchers join nationwide effort to use artificial intelligence in study of Alzheimer's disease

A new $17.8 million grant will help researchers discover novel ways to prevent and treat Alzheimer’s disease through state-of-the-art artificial intelligence (AI) methods.

Christina Griffiths  |  Oct 15, 2020